Joel Isaacson & Co. LLC grew its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.2% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 44,011 shares of the company’s stock after purchasing an additional 68 shares during the quarter. Johnson & Johnson makes up approximately 1.1% of Joel Isaacson & Co. LLC’s portfolio, making the stock its 12th biggest position. Joel Isaacson & Co. LLC’s holdings in Johnson & Johnson were worth $5,822,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in JNJ. Lenox Wealth Advisors Inc. lifted its stake in Johnson & Johnson by 0.6% in the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock worth $116,000 after acquiring an additional 5 shares during the period. Harel Insurance Investments & Financial Services Ltd. lifted its stake in Johnson & Johnson by 241.0% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock worth $149,000 after acquiring an additional 841 shares during the period. Shine Investment Advisory Services Inc. purchased a new stake in Johnson & Johnson in the second quarter worth $177,000. Ullmann Financial Group Inc. purchased a new stake in Johnson & Johnson in the first quarter worth $186,000. Finally, Puplava Financial Services Inc. purchased a new stake in Johnson & Johnson in the second quarter worth $202,000. 65.93% of the stock is owned by institutional investors.

JNJ has been the subject of a number of research analyst reports. Zacks Investment Research raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research note on Thursday, July 27th. BMO Capital Markets reiterated a “buy” rating and issued a $145.00 price objective on shares of Johnson & Johnson in a report on Friday, September 1st. UBS AG reiterated a “buy” rating and issued a $148.00 price objective on shares of Johnson & Johnson in a report on Thursday, August 31st. Cowen and Company set a $147.00 price objective on Johnson & Johnson and gave the stock a “buy” rating in a report on Thursday, August 24th. Finally, Credit Suisse Group reiterated a “buy” rating on shares of Johnson & Johnson in a report on Friday, August 4th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Johnson & Johnson currently has an average rating of “Hold” and a consensus target price of $143.70.

Shares of Johnson & Johnson (NYSE:JNJ) opened at $138.00 on Friday. Johnson & Johnson has a twelve month low of $109.32 and a twelve month high of $144.35. The company has a market capitalization of $370,739.75, a PE ratio of 19.33, a P/E/G ratio of 2.80 and a beta of 0.82. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The company had revenue of $19.65 billion during the quarter, compared to the consensus estimate of $19.29 billion. During the same period last year, the company earned $1.68 EPS. Johnson & Johnson’s revenue for the quarter was up 10.3% on a year-over-year basis. analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be issued a $0.84 dividend. The ex-dividend date is Monday, November 27th. This represents a $3.36 annualized dividend and a yield of 2.43%. Johnson & Johnson’s payout ratio is 58.33%.

TRADEMARK VIOLATION NOTICE: “Joel Isaacson & Co. LLC Has $5.82 Million Stake in Johnson & Johnson (JNJ)” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2017/11/19/joel-isaacson-co-llc-has-5-82-million-stake-in-johnson-johnson-jnj.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.